Vivet Therapeutics SAS
1 clinical trials · Sponsor
◉ Watch Vivet Therapeutics SAS
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (NCT04537377) | Vivet Therapeutics SAS | 2021-09-03 |
Track Vivet Therapeutics SAS automatically
Every clearance here is in the API, with alerts when new ones post.